FDA Inspection 759625 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on December 19, 2011 in Fort Lauderdale, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 19, 2011
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Fort Lauderdale, FL (United States)